Healthcare stocks rose Wednesday afternoon, with the NYSE Healthcare Index up 0.4% and the State Street Health Care Select Sector SPDR ETF (XLV) increasing 0.2%.
The iShares Biotechnology ETF (IBB) added 0.5%.
In corporate news, Corcept Therapeutics (CORT) shares jumped past 6% after the firm said Wednesday it will resubmit its new drug application to the US Food and Drug Administration in the coming weeks for relacorilant to treat Cushing's syndrome, also known as hypercortisolism.
Boston Scientific (BSX) shares slumped 12% after Chief Executive Mike Mahoney said this year has been "a bit more of a challenge" than anticipated.
Guardant Health (GH) shares gained 5.8% after the firm said its Shield blood test has been included in the American Cancer Society's updated Colorectal Cancer Screening guidelines.